ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,933, issued on May 20, was assigned to STEMRIM INC. (Osaka, Japan) and OSAKA UNIVERSITY (Osaka, Japan).

"Disease treatment drug based on mesenchymal-stem-cell mobilization" was invented by Katsuto Tamai (Osaka, Japan), Takashi Shimbo (Osaka, Japan) and Takehiko Yamazaki (Osaka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present inventors identified many nuclear proteins contained in the extract of skin tissue by mass spectrometry, randomly selected multiple partial amino acid sequences of the nuclear proteins, chemically synthesized peptides consisting of the partial amino acid sequences, and examined their activity of mobilizing mesen...